Errata (DOI:10.1016/j.jada.2007.12.009);Probiotics and Prebiotics in Dietetics Practice

Journal of the American Dietetic Association

Volumn 108, Issue 3, 2008, Pages 510-521

  Douglas, Linda C ^a   Sanders, Mary E ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIA (MICROORGANISMS);

EID: 39649125179     PISSN: 00028223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jada.2008.06.445     Document Type: Erratum

References (84)

1. Food and Agriculture Organization of the United Nations, and World Health Organization. Health and nutritional properties of probiotics in food, including powder milk with live lactic acid bacteria. World Health Organization Web site. http://www.who.int/foodsafety/publications/fs_management/en/probiotics.pdf Accessed December 17, 2006
2. Dixon B. Secrets of the Bulgarian bacillus. Lancet Infect Dis 2 (2002) 260
3. Backhed F., Ley R.E., Sonnenburg J.L., Peterson D.A., and Gordon J.I. Host-bacterial mutualism in the human intestine. Science 307 (2005) 1915-1920
4. Eckburg P.B., Bik E.M., Bernstein C.N., Purdom E., Dethlefsen L., Sargent M., Gill S.R., Nelson K.E., and Relman D.A. Diversity of the human intestinal microbial flora. Science 308 (2005) 1635-1638
5. Bengmark S. Bacteria for optimal health. Nutrition 16 (2000) 611-615
6. Guarner F., Bourdet-Sicard R., Brandtzaeg P., Gill H.S., McGuirk P., van Eden W., Versalovic J., Weinstock J.V., and Rook G.A. Mechanisms of disease: The hygiene hypothesis revisited. Nat Clin Pract Gastroenterol Hepatol 3 (2006) 275-284
7. Simakachorn N., Pichaipat V., Rithipornpaisarn P., Kongkaew C., Tongpradit P., and Varavithya W. Clinical evaluation of the addition of lyophilized, heat-killed Lactobacillus acidophilus LB to oral rehydration therapy in the treatment of acute diarrhea in children. J Pediatr Gastroenterol Nutr 30 (2000) 68-72
8. Sanders M.E. 10 myths about probiotics. Prepared Foods 7 (2005) 67-73
9. Sanders M.E. Probiotics: Considerations for human health. Nutr Rev 61 (2003) 91-99
10. Marteau P., Seksik P., Lepage P., and Doré J. Cellular and physiological effects of probiotics and prebiotics. Mini Rev Med Chem 4 (2004) 889-896
11. Rastall R.A., Gibson G.R., Gill H.S., Guarner F., Klaenhammer T.R., Pot B., Reid G., Rowland I.R., and Sanders M.E. Modulation of the microbial ecology of the human colon by probiotics, prebiotics and synbiotics to enhance human health: an overview of enabling science and potential applications. FEMS Microbiol Ecol 52 (2005) 145-152
12. Floch M.H., and Montrose D.C. Use of probiotics in humans: An analysis of the literature. Gastroenterol Clin North Am 34 (2005) 547-570
13. Jenkins B., Holsten S., Bengmark S., and Martindale R. Probiotics: A practical review of their role in specific clinical scenarios. Nutr Clin Pract 20 (2005) 262-270
14. Marco M.L., Pavan S., and Kleerebezem M. Towards understanding molecular modes of probiotic action. Curr Opin Biotechnol 17 (2006) 204-210
15. Plummer S., Weaver M.A., Harris J.C., Dee P., and Hunter J. Clostridium difficile pilot study: Effects of probiotic supplementation on the incidence of C. difficile diarrhoea. Int Microbiol 7 (2004) 59-62
16. Joint Food and Agriculture Organization of the United Nations/World Health Organization Working Group on Drafting Guidelines for the Evaluation of Probiotics in Food. Guidelines for the Evaluation of Probiotics in Food. Swedish South Asian Network for Fermented Food Web site. http://www.fermented-foods.net/wgreport2.pdf Accessed December 17, 2006
17. Gill H.S. Probiotics to enhance anti-infective defences in the gastrointestinal tract. Best Pract Res Clin Gastroenterol 17 (2003) 755-773
18. Bengmark S. Use of some pre-, pro- and synbiotics in critically ill patients. Best Pract Res Clin Gastroenterol 17 (2003) 833-848
19. Tamboli C.P., Caucheteux C., Cortot A., Colombel J.F., and Desreumaux P. Probiotics in inflammatory bowel disease: A critical review. Best Pract Res Clin Gastroenterol 17 (2003) 805-820
20. Mimura T., Rizzello F., Helwig U., Poggioli G., Schreiber S., Talbot I.C., Nicholls R.J., Gionchetti P., Campieri M., and Kamm M.A. Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. Gut 53 (2004) 108-114
21. Van Niel C.W., Feudtner C., Garrison M.M., and Christakis D.A. Lactobacillus therapy for acute infectious diarrhea in children: A meta-analysis. Pediatrics 109 (2002) 678-684
22. Kalliomaki M., Salminen S., Poussa T., Arvilommi H., and Isolauri E. Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet 361 (2003) 1869-1871
23. de Vrese M., Stegelmann A., Richter B., Fenselau S., Laue C., and Schrezenmeir J. Probiotics-Compensation for lactase insufficiency. Am J Clin Nutr 73 suppl (2001) S421-S429
24. Anukam K., Osazuwa E., Ahonkhai I., Ngwu M., Osemene G., Bruce A.W., and Reid G. Augmentation of antimicrobial metronidazole therapy of bacterial vaginosis with oral probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14: Randomized, double-blind, placebo controlled trial. Microbes Infect 8 (2006) 1450-1454
25. Anukam K.C., Osazuwa E., Osemene G.I., Ehigiagbe F., Bruce A.W., and Reid G. Clinical study comparing probiotic Lactobacillus GR-1 and RC-14 with metronidazole vaginal gel to treat symptomatic bacterial vaginosis. Microbes Infect 8 (2006) 2772-2776
26. Saggioro A. Probiotics in the treatment of irritable bowel syndrome. J Clin Gastroenterol 38 suppl 6 (2004) S104-S106
27. Niedzielin K., Kordecki H., and Birkenfeld B. A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome. Eur J Gastroenterol Hepatol 13 (2001) 1143-1147
28. Cremonini F., Di Caro S., Nista E.C., Bartolozzi F., Capelli G., Gasbarrini G., and Gasbarrini A. Meta-analysis: The effect of probiotic administration on antibiotic-associated diarrhoea. Aliment Pharmacol Ther 16 (2002) 1461-1467
29. Lionetti E., Miniello V.L., Castellaneta S.P., Magista A.M., de Canio A., Maurogiovanni G., Ierardi E., Cavallo L., and Francavilla R. Lactobacillus reuteri therapy to reduce side effects during anti-Helicobacter pylori treatment in children: A randomized placebo controlled trial. Aliment Pharmacol Ther 24 (2006) 1461-1468
30. Nase L., Hatakka K., Savilahti E., Saxelin M., Ponka A., Poussa T., Korpela R., and Meurman J.H. Effect of long-term consumption of a probiotic bacterium, Lactobacillus rhamnosus GG, in milk on dental caries and caries risk in children. Caries Res 35 (2001) 412-420
31. Hatakka K., Savilahti E., Ponka A., Meurman J.H., Poussa T., Nase L., Saxelin M., and Korpela R. Effect of long-term consumption of probiotic milk on infections in children attending day care centres: Double blind, randomised trial. BMJ 322 (2001) 1327
32. de Vrese M., Winkler P., Rautenberg P., Harder T., Noah C., Laue C., Ott S., Hampe J., Schreiber S., Heller K., and Schrezenmeir J. Effect of Lactobacillus gasseri PA 16/8, Bifidobacterium longum SP 07/3, B. bifidum MF 20/5 on common cold episodes: A double blind, randomized, controlled trial. J Clin Nutr 24 (2005) 481-491
33. Tubelius P., Stan V., and Zachrisson A. Increasing workplace healthiness with the probiotic Lactobacillus reuteri: A randomised, double-blind placebo-controlled study. Environ Health 7 (2005) 4 25
34. Weizman Z., Asli G., and Alsheikh A. Effect of a probiotic infant formula on infections in child care centers: Comparison of two probiotic agents. Pediatrics. 115 (2005) 5-9
35. Thomas M.R., Litin S.C., Osmon D.R., Corr A.P., Weaver A.L., and Lohse C.M. Lack of effect of Lactobacillus GG on antibiotic-associated diarrhea: A randomized, placebo-controlled trial. Mayo Clin Proc 76 (2001) 883-889
36. Anderson A.D., McNaught C.E., Jain P.K., and MacFie J. Randomised clinical trial of synbiotic therapy in elective surgical patients. Gut 53 (2004) 241-245
37. McNaught C.E., Woodcock N.P., MacFie J., and Mitchell C.J. A prospective randomised study of the probiotic Lactobacillus plantarum 299V on indices of gut barrier function in elective surgical patients. Gut 51 (2002) 827-831
38. O'Sullivan M.A., and O'Morain C.A. Bacterial supplementation in the irritable bowel syndrome. A randomised double-blind placebo-controlled crossover study. Dig Liver Dis 32 (2000) 294-301
39. Marteau P., Lemann M., Seksik P., Laharie D., Colombel J.F., Bouhnik Y., Cadiot G., Soule J.C., Bourreille A., Metman E., Lerebours E., Carbonnel F., Dupas J.L., Veyrac M., Coffin B., Moreau J., Abitbol V., Blum-Sperisen S., and Mary J.Y. Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn's disease: A randomised, double blind, placebo controlled GETAID trial. Gut 55 (2006) 842-847
40. Pirotta M., Gunn J., Chondros P., Grover S., O'Malley P., Hurley S., and Garland S. Effect of Lactobacillus in preventing post-antibiotic vulvovaginal candidiasis: A randomised controlled trial. BMJ 329 (2004) 548
41. Breidt Jr. F., McFeeters R.F., and Diaz-Muniz I. Fermented vegetables. In: Doyle M.P., and Beuchat L.R. (Eds). Food Microbiology: Fundamentals and Frontiers. 3rd ed. (2007), ASM Press, Washington, DC 783-793
42. Mimura T., Rizzello F., Helwig U., Poggioli G., Schreiber S., Talbot I.C., Nicholls R.J., Gionchetti P., Campieri M., and Kamm M.A. Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. Gut 53 (2004) 108-114
43. Champagne C.P., and Fustier P. Microencapsulation for the improved delivery of bioactive compounds into foods. Curr Opin Biotechnol 18 (2007) 184-190
44. Center for Food Safety and Applied Nutrition Office of Nutritional Products, Labeling, and Dietary Supplements. Guidance for Industry: Substantiation for Dietary Supplement Claims Made Under Section 403(r) (6) of the Federal Food, Drug, and Cosmetic Act. US Food and Drug Administration Web site. http://www.cfsan.fda.gov/∼dms/dsclmgui.html Accessed December 17, 2006
45. Sanders M.E., and Heimbach J. Functional foods in the USA: Emphasis on probiotic-containing foods. Food Sci Technol Bull Funct Foods 1 (2004) 1-10
46. Sanders M.E., Tompkins T., Heimbach J., and Kolida S. Weight of evidence needed to substantiate a health effect for probiotics and prebiotics: Scientific and regulatory considerations in Canada, EU, and US. Eur J Nutr 44 (2004) 303-310
47. Hamilton-Miller J.M., and Shah S. Deficiencies in microbiological quality and labelling of probiotic supplements. Int J Food Microbiol 72 (2002) 175-176
48. Gibson G.R., and Roberfroid M.B. Dietary modulation of the human colonic microbiotia: Introducing the concept of prebiotics. J Nutr 125 (1995) 1401-1412
49. Bournet F.R., Brouns F., Tashiro Y., and Duvillier V. Nutritional aspects of short-chain fructooligosaccharides: Natural occurrence, chemistry, physiology, and health implications. Dig Liver Dis 34 suppl 2 (2002) S111-S120
50. Hidaka H., Hirayama M., Tokunaga T., and Eida T. The effects of undigestible fructooligosaccharides on intestinal microflora and various physiological functions on human health. Adv Exp Med Biol 270 (1990) 105-117
51. Tokunaga T. Novel physiological function of fructooligosaccharides. Biofactors 21 (2004) 89-94
52. Scheppach W., Luehrs H., and Menzel T. Beneficial health effects of low-digestible carbohydrate consumption. Br J Nutr 85 suppl (2001) S23-S30
53. Grizard D., and Barthomeuf C. Non-digestible oligosaccharides used as prebiotic agents: Mode of production and beneficial effects on animal and human health. Reprod Nutr Dev 39 (1999) 563-588
54. Flamm G., Glinsmann W., Kritchevsky D., Prosky L., and Roberfroid M. Inulin and oligofructose as dietary fiber: A review of the evidence. Crit Rev Food Sci Nutr 41 (2001) 353-362
55. Pool-Zobel B., van Loo J., Rowland I., and Roberfroid M.B. Experimental evidences on the potential of prebiotic fructans to reduce the risk of colon cancer. Br J Nutr 87 suppl 2 (2002) S273-S281
56. Cummings J.H., Macfarlane G.T., and Englyst H.N. Prebiotic digestion and fermentation. Am J Clin Nutr 73 suppl 2 (2001) S415-S420
57. Roberfroid M.B. Health benefits of non-digestible oligosaccharides. Adv Exp Med Biol 427 (1997) 211-219
58. Forchielli M.L., and Walker W.A. The role of gut-associated lymphoid tissues and mucosal defence. Br J Nutr 93 suppl 1 (2005) S41-S48
59. Priebe M.G., Vonk R.J., Sun X., He T., Harmsen H.J.M., and Welling G.W. The physiology of colonic metabolism. Possibilities for interventions with pre- and probiotics. Eur J Nutr 41 suppl 1 (2002) S2-S10
60. Blaut M. Relationship of prebiotics and food to intestinal microflora. Eur J Nutr 41 suppl 1 (2002) S11-S16
61. Winter D. Probiotic and prebiotic foods. Baylor Health Care System Web site. http://www.baylorhealth.com/healthinformation/healthsource/2005/march/03-21-mon.htm Accessed December 17, 2006
62. Dixon S. Prebiotics and probiotics: What are they and why should I eat them?. University of Michigan Comprehensive Cancer Center Web site. http://www.cancer.med.umich.edu/news/pro09spr02.htm Accessed December 17, 2006
63. Charalampopoulos D., Wang R., Pandiella S.S., and Webb C. Application of cereals and cereal components in functional foods: A review. Int J Food Microbiol 79 (2002) 131-141
64. Slavin J. Why whole grains are protective: Biological mechanisms. Proc Nutr Soc 62 (2003) 129-134
65. Tahiri M., Tressol J.C., Arnaud J., Bournet F., Bouteloup-Demange C., Feillet-Coudray C., Ducros V., Pepin D., Brouns F., Rayssiguier A.M., and Coudray C. J Bone Miner Res 16 (2001) 2152-2160
66. Scholz-Ahrens K.E., Schaafsma G., and van den Heuvel E.G. Effects of prebiotics on mineral metabolism. Am J Clin Nutr 73 suppl (2001) 459S-464S
67. Brugger A. Inulin studies in humans: Overview of heath benefits. US Pharmacist Web Site. http://www.uspharmacist.com/oldformat.asp?url=publish/content/8_1862.htm Accessed December 17, 2006
68. Chow J. Probiotics and prebiotics: A brief overview. J Ren Nutr 12 (2002) 76-86
69. Douglas L.C. Prebiotic overview. Nutraceuticals World 6 (2003) 80-83
70. Resistant starch-Questions and answers. British Nutrition Foundation Web site. http://www.nutrition.org.uk/upload/Resistant%20Starch(1).pdf Accessed April 16, 2007
71. Jacobasch G., Schmied D., Kruschewski M., and Schmehl K. Dietary resistant starch and chronic inflammatory bowel diseases. Int J Colorectal Dis. 14 (1999) 201-211
72. Topping D.L., and Clifton F.M. Short-chain fatty acids and human colonic function: Roles of resistant starch and nonstarch polysaccharides. Physiol Rev 81 (2001) 1031-1064
73. Brown I.L. Applications and uses of resistant starch. J AOAC Int 87 (2004) 727-732
74. Cassidy A., Bingham S.A., and Cummings J.H. Starch intake and colorectal cancer risk: An international comparison. Br J Cancer 69 (1994) 119-125
75. Bounik Y., Raskine L., Simoneau G., Vicaut E., Neut C., Flourie B., Brouns F., and Bournet F.R. The capacity of nondigestible carbohydrates to stimulate fecal bifidobacteria in healthy humans: A double-blind, randomized, placebo-controlled, parallel-group, dose-response relation study. Am J Clin Nutr. 80 (2004) 1658-1664
76. Whelan K., Judd P.A., Preedy V.R., Simmering R., Jann A., and Taylor M.A. Fructooligosaccharides and fiber partially prevent the alterations in fecal microbiotia and short-chain fatty acid concentrations caused by standard enteral formula in healthy humans. J Nutr 135 (2005) 1896-1902
77. Seidner D.L., Lashner B.A., Brzezinski A., Banks P.L., Goldblum J., Fiocchi C., Katz J., Lichtenstein G.R., Anton P.A., Kam L.Y., Garleb K.A., and Demichele S.J. An oral supplement enriched with fish oil, soluble fiber, and antioxidants for corticosteroid sparing in ulcerative colitis: A randomized, controlled trial. Clin Gastroenterol Hepatol 3 (2005) 358-369
78. Younes H., Alphonse J.C., Hadj-Adbelkader M., and Remesy C. Fermentable carbohydrates and digestive nitrogen excretion. J Ren Nutr 3 (2001) 139-148
79. Younes H., Garleb K., Behr S., Remesy C., and Demigne C. Fermentable fibers or oligosaccharides reduce urinary nitrogen excretion by increasing urea disposal in the rat cecum. J Nutr 125 (1995) 1010-1016
80. Cockram D.B., Hensley M.K., Rodriguez M., Agarwal G., Wennberg A., Ruey P., Ashback D., Hebert L., and Kunau R. Safety and tolerance of medical nutritional products as sole sources of nutrition in people on hemodialysis. J Ren Nutr 8 (1998) 25-33
81. Ross Products Division. Ross Medical Nutrition Pocket Guide (2005), Abbot Laboratories, Columbus, OH
82. Wolf B.W., Chow J.M., and Garleb K.A. Medical foods and fructooligosaccharides. In: Dimitriu S. (Ed). Polysaccharides: Structural Diversity and Functional Versatility. 2nd ed. (2005), Marcel Dekker, New York, NY 853-866
83. US Food and Drug Administration, Center for Food Safety and Applied Nutrition, Office of Food Additive Safety. Agency GRAS response letter. US Food and Drug Administration Web site. http://www.cfsan.fda.gov/∼rdb/opa-g118.html Accessed on April 16, 2007
84. Swanson K.S., Grieshop C.M., Flickinger E.A., Bauer L.L., Wolf B.W., Chow J., Garleb K.A., Williams J.A., and Fahey Jr. G.C. Fructooligosaccharides and Lactobacillus acidophilus modify bowel function and protein catabolites excreted by healthy humans. J Nutr 132 (2002) 3042-3050